Frank Agbogbo BSc, PhD

Frank has over 16 years of experience in academia and industry. He is currently the Director of Microbial Bioprocess at Cytovance Biologics and he has been with the company since May 2014. Prior to Cytovance, Frank was a Scientist at Novozymes, ICM, Inc., and Mascoma Corporation. He also served as Application Technology Manager at Mascoma Corporation where he contributed to the FDA approval and launch of two commercial products.
His background includes microbial process development, Design of experiments, Process Optimization, Process Characterization and Scale-Up from R&D to Manufacturing (cGMP and non-cGMP). Frank oversees the Microbial Bioprocess development group at Cytovance Biologics and has been responsible for transferring processes from clients to R&D and to cGMP manufacturing. He was a presenter and Co-Chair at scientific conferences such as Society for Industrial Microbiology and Biotechnology (SIMB) and Recent Advances in Fermentation Technology (RAFT).